Advertising
Advertising
twitter
youtube
facebook
instagram
linkedin
Advertising

Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime Impact

Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime Impact
Aa
Share
facebook
twitter
linkedin

Table of contents

  1. Bioton – (Last valuation: 5.41 PLN/share as of 19.09.2023) 3Q23 results - below our expectations, slightly negative

    Bioton – (Last valuation: 5.41 PLN/share as of 19.09.2023) 3Q23 results - below our expectations, slightly negative

    Revenues in 3Q23 amounted to PLN 50.7 million (vs. PLN 50 million of our forecast), EBIT amounted to PLN -2 million (vs. PLN -1 million of our forecast), and EBITDA amounted to PLN 3.9 million (vs. PLN 10.6 million - we assumed depreciation and amortization at PLN 11.5 million, and in the end it turned out to be much lower at PLN 5.9 million), net result amounted to PLN -4.4 million (vs. PLN -2.9 million of our forecast).

    In line with our expectations, Q3 2022 was a high base both in terms of revenue and margins - the company made more export sales with higher profitability during this period. The result on the operating level in 3Q23 was further supported by a positive balance on other operating activities of +3.8 million PLN. Adjusted for this factor, the operating result in 3Q23 was PLN -5.8 million.

    The company additionally pointed to the negative impact of production downtime on profitability. In a management commentary, the company said it had called on Yifan to pay PLN 8.8 million for work done on the Glargine project, including the cost of the API plant shutdown during its modification. We view the results slightly negatively.

     

    bioton s 3q23 financial performance below expectations with production downtime impact grafika numer 1bioton s 3q23 financial performance below expectations with production downtime impact grafika numer 1


    GPW’s Analytical Coverage Support Programme 3.0

    GPW’s Analytical Coverage Support Programme 3.0

    The Warsaw Stock Exchange's (GPW's) Analytical Coverage Support Programme 3.0 supports investment firms in drafting analytical reports which are financed by GPW. The objective of the Programme is to improve the availability of research covering less liquid companies, facilitating investors' informed investment decisions based on a reliable independent source of issuer information. Eligible to participate in the Programme are companies listed on the GPW Main Market (other than WIG20 participants) and on NewConnect. The Programme covers up to 50 issuers.

    Twitter | LinkedIn 


    Advertising
    Advertising